Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines
- PMID: 27841133
- PMCID: PMC4873907
- DOI: 10.1017/S002221511600058X
Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines
Abstract
This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. A rational plan to manage the neck is necessary for all head and neck primaries. With the emergence of new level 1 evidence across several domains of neck metastases, this guideline will identify the evidence-based recommendations for management. Recommendations • Computed tomographic or magnetic resonance imaging is mandatory for staging neck disease, with choice of modality dependant on imaging modality used for the primary site, local availability and expertise. (R) • Patients with a clinically N0 neck, with more than 15-20 per cent risk of occult nodal metastases, should be offered prophylactic treatment of the neck. (R) • The treatment choice of for the N0 and N+ neck should be guided by the treatment to the primary site. (G) • If observation is planned for the N0 neck, this should be supplemented by regular ultrasonograms to ensure early detection. (R) • All patients with T1 and T2 oral cavity cancer and N0 neck should receive prophylactic neck treatment. (R) • Selective neck dissection (SND) is as effective as modified radical neck dissection for controlling regional disease in N0 necks for all primary sites. (R) • SND alone is adequate treatment for pN1 neck disease without adverse histological features. (R) • Post-operative radiation for adverse histologic features following SND confers control rates comparable with more extensive procedures. (R) • Adjuvant radiation following surgery for patients with adverse histological features improves regional control rates. (R) • Post-operative chemoradiation improves regional control in patients with extracapsular spread and/or microscopically involved surgical margins. (R) • Following chemoradiation therapy, complete responders who do not show evidence of active disease on co-registered positron emission tomography-computed tomography (PET-CT) scans performed at 10-12 weeks, do not need salvage neck dissection. (R) • Salvage surgery should be considered for those with incomplete or equivocal response of nodal disease on PET-CT. (R).
Figures
Similar articles
-
Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines.J Laryngol Otol. 2016 May;130(S2):S181-S190. doi: 10.1017/S002221511600061X. J Laryngol Otol. 2016. PMID: 27841130 Free PMC article.
-
Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.J Laryngol Otol. 2016 May;130(S2):S150-S160. doi: 10.1017/S0022215116000578. J Laryngol Otol. 2016. PMID: 27841128 Free PMC article.
-
Head and neck melanoma (excluding ocular melanoma): United Kingdom National Multidisciplinary Guidelines.J Laryngol Otol. 2016 May;130(S2):S133-S141. doi: 10.1017/S0022215116000852. J Laryngol Otol. 2016. PMID: 27841141 Free PMC article.
-
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all?Head Neck. 2006 Feb;28(2):166-75. doi: 10.1002/hed.20302. Head Neck. 2006. PMID: 16240327 Review.
-
Controversies in surgical management of the node-positive neck after chemoradiation.Semin Radiat Oncol. 2009 Jan;19(1):24-8. doi: 10.1016/j.semradonc.2008.09.005. Semin Radiat Oncol. 2009. PMID: 19028342 Review.
Cited by
-
Diagnostic value of 3D dynamic contrast-enhanced magnetic resonance imaging in lymph node metastases of head and neck tumors: a correlation study with histology.Acta Radiol Open. 2020 Aug 26;9(8):2058460120951966. doi: 10.1177/2058460120951966. eCollection 2020 Aug. Acta Radiol Open. 2020. PMID: 32922960 Free PMC article.
-
Management of the Contralateral Neck in Unilateral Node-Positive Oral Squamous Cell Carcinoma.Cancers (Basel). 2023 Feb 8;15(4):1088. doi: 10.3390/cancers15041088. Cancers (Basel). 2023. PMID: 36831429 Free PMC article.
-
Advances and residual knowledge gaps in the neck management of head and neck squamous cell carcinoma patients with advanced nodal disease undergoing definitive (chemo)radiotherapy for their primary.Strahlenther Onkol. 2024 Jul;200(7):553-567. doi: 10.1007/s00066-024-02228-4. Epub 2024 Apr 10. Strahlenther Onkol. 2024. PMID: 38600366 Review.
-
Nutrition in Cancer Therapy in the Elderly-An Epigenetic Connection?Nutrients. 2020 Nov 1;12(11):3366. doi: 10.3390/nu12113366. Nutrients. 2020. PMID: 33139626 Free PMC article. Review.
-
Diplopia: a unique presentation of recurrence of a salivary gland carcinoma.BMJ Case Rep. 2019 May 5;12(5):e225243. doi: 10.1136/bcr-2018-225243. BMJ Case Rep. 2019. PMID: 31061174 Free PMC article.
References
-
- de Bondt RB, Nelemans PJ, Hofman PA, Casselman JW, Kremer B, van Engelshoven JM et al. Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol 2007;64:266–72 - PubMed
-
- Paleri V, Rees G, Arullendran P, Shoaib T, Krishman S. Sentinel node biopsy in squamous cell cancer of the oral cavity and oral pharynx: a diagnostic meta-analysis. Head Neck 2005;27:739–47 - PubMed
-
- Schilling C, Stoeckli SJ, Haerle SK, Broglie MA, Huber GF, Sorensen JA. Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer. Eur J Ca 2015;51:2777–84 - PubMed
-
- Robbins KT, Clayman G, Levine PA, Medina J, Sessions R, Shaha A et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 2002;128:751–8 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous